{"id":"W2898234770","doi":"10.1093/annonc/mdy289.062","title":"ILLUMINATE 301: A randomized phase III comparison of IMO-2125 with ipilimumab (ipi) versus ipi alone in subjects with anti PD 1 refractory melanoma","year":2018,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Ipilimumab; Internal medicine; Melanoma; Clinical endpoint; Refractory (planetary science); Phases of clinical research; Oncology; Progressive disease; Clinical trial; Gastroenterology; Immunotherapy; Chemotherapy; Cancer; Cancer research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002052068,0.00224363,0.002607182,0.0004954391,0.0005571877,0.001219037,0.001251278,0.002131916,0.008669656],"category_scores_gemma":[0.001358797,0.0009231133,0.001534721,0.0004471513,0.001571661,0.001372987,0.0005852546,0.003631535,0.001888165],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009048596,"about_ca_system_score_gemma":0.001790503,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009148381,"about_ca_topic_score_gemma":0.002418354,"domain_scores_codex":[0.9993074,0.000365773,0.0000342172,0.0001248378,0.0000506346,0.000117156],"domain_scores_gemma":[0.9992009,0.0001838521,0.0001583676,0.00006080269,0.00004682695,0.0003492369],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9699719,0.01323842,0.000394261,0.0004085652,0.0003569754,0.00003139472,0.00005512641,0.000274587,0.005394712,0.0001241916,0.0008973249,0.008852564],"study_design_scores_gemma":[0.8814125,0.116044,0.0009376114,0.00001791709,0.0001731746,0.0000288369,0.00001967042,0.0002983618,0.0003939458,0.0001381466,0.0005224783,0.00001345542],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9782302,0.001961818,0.0008838626,0.0008401424,0.0005091102,0.01168837,0.002019068,0.0002244189,0.003643045],"genre_scores_gemma":[0.9714445,0.001626985,0.002571463,0.001942815,0.0005264144,0.01407572,0.002062566,0.00006394114,0.005685504],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008669656,"threshold_uncertainty_score":0.02900285,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06381902280130473,"score_gpt":0.3998208149114062,"score_spread":0.3360017921101014,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}